Synthetic biology pioneer Twist to cut 212 jobs

The company had nearly $390 million in cash, equivalents and investments at the end of March, but biotech companies are paring costs in the wake of a generalist investor pullout.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news